Abstract
Background People with bipolar disorder (BPD) are more likely to die prematurely, which is partly attributed to comorbid cardiometabolic traits. BPD has a bidirectional relationship with cardiometabolic traits, but their shared etiology is poorly understood. This study aimed to examine the phenotypic associations and shared genetic etiology between BPD and various cardiometabolic traits.
Methods In a subset of the UK Biobank sample (N = 67,317) we investigated phenotypic associations between BPD (n = 4,155) and cardiometabolic traits, represented by biomarkers, anthropometric traits and cardiometabolic diseases. To determine the shared genetic etiology, polygenic risk scores and genetic correlations were calculated between BPD and these traits.
Results Several cardiometabolic traits were significantly associated with increased risk for BPD, namely low total cholesterol, low high-density lipoprotein cholesterol, high triglycerides, high glycated haemoglobin (HbA 1c), low systolic blood pressure, high body mass index, high waist-to-hip ratio, as well as stroke, coronary artery disease and type 2 diabetes diagnosis. Polygenic risk score regressions showed that higher polygenic risk for triglycerides, waist-to-hip ratio, coronary artery disease, and type 2 diabetes was associated with increased risk for bipolar disorder. These associations were not replicated when using genetic correlations.
Conclusions This large study identified phenotypic cardiometabolic risk factors for BPD. Moreover, it found that comorbidities between BPD and waist-to-hip ratio, triglycerides, type 2 diabetes and coronary artery disease may be based on shared genetic etiology. These results provide a better understanding of the phenotypic and genetic comorbidity between BPD and cardiometabolic traits.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AEF is funded by the Social, Genetic and Developmental Psychiatry Centre, King’s College London and the National Institute of Health grant R01AG054628. SPH is funded by the Medical Research Council (MR/S0151132). JT is supported by an Academy of Medical Sciences (AMS) Springboard award, which is supported by the AMS, the Wellcome Trust, GCRF, the Government Department of Business, Energy and Industrial strategy, the British Heart Foundation and Diabetes UK (SBF004\1079). This study presents independent research supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR, Department of Health or King's College London. This study was conducted using UK Biobank data obtained under approved application 18177. We thank participants and scientists involved in making the UK Biobank resource available (http://www.ukbiobank.ac.uk/).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
UK Biobank is a publicly available controlled-access dataset available to any bona fide researcher. This study was conducted using UK Biobank data obtained under approved application 18177.
